Trial Profile
Evaluation of Safety and Efficacy of Treosulfan-cytarabine-fludarabine (FLAT) Combination Prior to Autologous Stem Cell Transplant (HSCT) in Elderly Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Filgrastim (Primary) ; Fludarabine (Primary) ; Treosulfan (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms FLATauto
- 18 Jul 2022 Status changed from active, no longer recruiting to completed.
- 11 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 29 Jul 2011 New trial record